We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
- Authors
Wozniak, A J; Crowley, J J; Balcerzak, S P; Weiss, G R; Spiridonidis, C H; Baker, L H; Albain, K S; Kelly, K; Taylor, S A; Gandara, D R; Livingston, R B
- Abstract
Cisplatin has played a major role in the treatment of non-small-cell lung cancer (NSCLC). This randomized trial was performed by the Southwest Oncology Group (SWOG) to determine whether the combination of vinorelbine and cisplatin has any advantage with regard to response rate, survival, and time to treatment failure over single-agent cisplatin in the treatment of patients with advanced NSCLC.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Vol 16, Issue 7, p2459
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1998.16.7.2459